BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 1720380)

  • 1. Schistosomiasis drug therapy and treatment considerations.
    Shekhar KC
    Drugs; 1991 Sep; 42(3):379-405. PubMed ID: 1720380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of 700 cases of bilharziasis with the new drugs oxamniquine, oltipraz, praziquantel].
    Lapierre J; Keita A; Faurant C; Heyer F; Tourte-Schaefer C; Ancelle T; Dupouy-Camet J
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):526-33. PubMed ID: 6673843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of schistosomiasis mansoni].
    de Carvalho SA
    Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically available antischistosomal drugs.
    Davis A
    J Toxicol Environ Health; 1975 Nov; 1(2):191-201. PubMed ID: 1206768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
    Xiao SH; Sun J; Chen MG
    Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.
    Doenhoff M; Bickle Q; Bain J; Webbe G; Nelson G
    J Helminthol; 1980 Mar; 54(1):7-16. PubMed ID: 7373025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in schistosomiasis: a review.
    Bruce JI; Dias LC; Liang YS; Coles GC
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():143-50. PubMed ID: 3151088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot control trial of schistosomiasis in central Liberia by mass chemotherapy of target populations, combined with focal application of molluscicide.
    Saladin B; Saladin K; Holzer B; Dennis E; Hanson A; Degrémont A
    Acta Trop; 1983 Sep; 40(3):271-95. PubMed ID: 6138977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for treating schistosomiasis mansoni.
    Saconato H; Atallah A
    Cochrane Database Syst Rev; 2000; (2):CD000528. PubMed ID: 10796552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 13. [Schistosomiasis: diagnosis and treatment].
    Ripert C
    Presse Med; 2000 Sep; 29(28):1583-5. PubMed ID: 11072382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites.
    Utzinger J; Xiao S; Keiser J; Chen M; Zheng J; Tanner M
    Curr Med Chem; 2001 Dec; 8(15):1841-60. PubMed ID: 11772354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemotherapy of schistosomiasis.
    Archer S
    Annu Rev Pharmacol Toxicol; 1985; 25():485-508. PubMed ID: 3890709
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative trial of praziquantel, metrifonate and niridazole against Schistosoma haematobium.
    McMahon JE
    Ann Trop Med Parasitol; 1983 Apr; 77(2):139-42. PubMed ID: 6882062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report on long term cure of schistosomiasis using metrifonate (Bilarcil/Dipterex)--a new antischistosomal drug.
    Onadeko MO
    West Afr J Pharmacol Drug Res; 1979; 5(1):19-24. PubMed ID: 122130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.